Health Condition 1: H350- Background retinopathy and retinalvascular changes
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
Carl Zeiss India Bangalore Private Limited.
Eligibility
Inclusion criteria
Inclusion criteria: 1. Confirmed diagnosis of Type 1 or Type 2 Diabetes. 2. Patients who had consented to share their data for research and development purposes. 3. Patient data with the following stages of diabetic retinopathy (DR), with the respective distribution in the dataset: - Mild NPDR (10%) - Moderate NPDR (20%) - Severe NPDR (50%) - Proliferative DR (20%) 4. Within the dataset, a small subset of the data should also meet the following criterion: - Presence of Diabetic Macular Edema (DME) (5%)
Exclusion criteria
Exclusion criteria: 1. Patients who have not consented to share their data for research and development purposes. 2. Known history, within 6 months prior to the data of image acquisition, of retinal artery or retinal vein occlusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The retrospective study aims to collect OCTA image data and clinical information from 300 diabetic patients using the ZEISS PLEX Elite 9000 OCT Angiography device. The outcome of this study is data collection for research and development purposes.Timepoint: The primary time point for data collection will be the baseline visit, defined as the first visit when the OCTA scan was performed using the ZEISS PLEX Elite 9000 OCTA Angiography device. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactMansi Gupta
Carl Zeiss India (Bangalore) Private Limited
Outcome results
None listed